Hunniwell Lake Ventures Spotlights NuvOx

NuvOx Pharma
Jul 15, 2020
1 min read

Hunniwell Lake Ventures interviews NuvOx Co-founder and CEO, Evan Unger MD.

Recent Posts

NuvOx Announces First Patient in Phase IIb Stroke Trial

Tucson, AZ –December 15, 2025, NuvOx Therapeutics, Inc. (“NuvOx”) announced that the first patient has been enrolled in the Phase IIb NOVEL trial (NanO 2 in Large Vessel Occlusion Stroke (NOVEL): a

NuvOx and Dr. Pavani Chalasani Announce acceptance of abstracts in Triple Negative Breast Cancer at 2 prestigious conventions - “Novel Oxygen Therapeutic Shows Promise in Boosting Immunotherapy”

Tucson, AZ – November 24, 2025 – Today NuvOx Therapeutics, Inc. (“NuvOx”) along with Dr. Pavani Chalasani of George Washington University announced the acceptance of abstracts in Triple Negative Bre

NuvOx Therapeutics Highlights Progress of RESTORE Phase II Trial of NanO₂™ in Newly Diagnosed Glioblastoma at the Society for Neuro-Oncology (SNO) 2025 Annual Meeting

Tucson, Arizona — November 12, 2025 — NuvOx Therapeutics, Inc. (“NuvOx”), a clinical-stage biotechnology company developing oxygen therapeutics to enhance the efficacy of cancer treatment, today annou

Comments